Brief: AcuCort Is Exempted From Application Fee By U.S. Food And Drug Administration
01/03/2022 17:27
March 1 (Reuters) - AcuCort AB ACUC.TE :
* ACUCORT IS EXEMPTED FROM APPLICATION FEE BY U.S. FOOD AND
DRUG
ADMINISTRATION
Source text for Eikon: ID:nWkr1HwsQl
Further company coverage: ACUC.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA